# Martin Varsavsky

> Martin Varsavsky is a seed investor at Goggo Network (Madrid) backing Software and Health Care. See 25 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Goggo Network](https://shizune.co/investors/profile/goggo-network)
- Location: Madrid, Spain
- Total investments: 25
- Last investment: Apr 2026
- Lead investor: 4%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/martinvarsavsky
- X (Twitter): https://twitter.com/martinvars
- Website: http://english.martinvarsavsky.net
- Facebook: http://www.facebook.com/martinvarsavsky

Martin Varsavsky is a seed investor at Goggo Network in Madrid focused on Software and Health Care. Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $424k–$3.3M |
| Angel | $212k–$1.1M |
| Series A | $4.3M–$77M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 5 | 20% |
| Health Care | 5 | 20% |
| Social Media | 5 | 20% |
| Medical Device | 3 | 12% |
| Apps | 2 | 8% |

74 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 11 | 44% |
| Series A | 5 | 20% |
| Angel | 2 | 8% |
| Series B | 2 | 8% |
| Series C | 2 | 8% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 40% |
| United Kingdom | 5 | 20% |
| Spain | 3 | 12% |
| Germany | 2 | 8% |
| Argentina | 2 | 8% |

8 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Betterness | Betterness is a technology platform focused on integrating artificial intelligence with health and wellness data to support individuals and service providers. The company develops an interconnected system that aggregates inputs from wearables, laboratory tests, and health records, enabling AI agents to analyze and act on real-time data within asingle environment. Its platform allows users to track biomarkers, manage health information, and access coordinated services such as lab ordering and provider discovery, while also supporting builders and organizations in creating AI-driven wellness applications. In addition, Betterness provides tools that enable wellness professionals to engage clients, automate workflows, and deliver personalized support through AI-assisted systems. Overall, the company positions its offering as an infrastructure layer that connects data, AI capabilities, and human expertise to streamline and coordinate activities across the wellness ecosystem. | $2.5M | Seed | Apr 24, 2026 |  |
| Shorta | Shorta is a mobile‑first platform for premium vertical fiction, delivering short‑form “micro‑series” designed specifically for phones and social‑style viewing. | $6M | Pre-Seed | Apr 22, 2026 |  |
| Humand | Humand provides companies to digitize their internal communication, culture, HR processes in one app.. | $77.5M | Series A | Feb 23, 2026 |  |
| Curative | Curative provides employer-based health insurance plans and healthcare services. The company delivers a plan with no copays, no deductibles, and a fixed monthly premium, aiming to make medical care easier to access and manage. It offers preventive care including an annual baseline visit, behavioral health services, primary and specialty care,prescription drug coverage, and integration with a network of providers. Curative also supports virtual care through its telehealth offering, enabling members to consult clinicians remotely for common health issues. Previously, the company was involved in large-scale diagnostic testing and vaccine distribution during the COVID-19 pandemic, and has since shifted focus to its insurance and care management services. | $150M | Series B | Nov 28, 2025 |  |
| Outdid | Outdid helps online apps, and services limit their data liability while giving their consumers peace of mind that their personal information is secure. | $2.5M | Seed | Jun 29, 2023 |  |
| Vitara Biomedical | Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care. | $75M | Series B | Sep 13, 2022 |  |
| TympaHealth | TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system empowers non-specialists to perform high definition digital otoscopy, microsuction wax removal and a hearing screening, all in a single 30 minute appointment. Users can also upload patient images and video to the secure cloud, where they canbe reviewed by ENT specialists anywhere in the world. | $8M | Seed | Feb 17, 2022 |  |
| Pomelo | Pomelo provides a cloud-native financial technology platform that enables businesses to issue, process, and manage payment cards and related services through modular APIs and infrastructure. Its technology supports the issuance and processing of credit, debit, and prepaid cards, including options for businesses without their own issuing licensethrough BIN sponsorship and integration with Mastercard and Visa networks. The company’s platform also includes tools for transaction authorization, chargeback handling, fraud monitoring, tokenization for digital wallets, and logistical support for card production and distribution. Pomelo’s offerings aim to streamline card program development by consolidating technical, regulatory, and operational components into a unified system that can be tailored to diverse use cases across fintech, banking, and embedded finance sectors. It supports virtual and physical card workflows and provides dashboards and management interfaces to monitor and control card portfolios and transactions. The company collaborates with clients to integrate its APIs into existing systems and scale card products across multiple markets. Pomelo’s infrastructure emphasizes flexibility, data visibility, and compliance with international payment standards. | $35M | Series A | Oct 21, 2021 |  |
| NUE Life Health | NUE Life aims to improve mental wellness by enhancing brain function, performance, and longevity through evidence-based and scientifically proven mental health treatments and products. NUE Life has created a therapeutic ecosystem of ketamine therapy, an interactive companion app, and virtual aftercare programs to help people heal. | $3.3M | Seed | Jun 03, 2021 |  |
| Hangry | Hangry connects brands with Uber and Cabify passengers, transforming rides into a place to shop and try new products | $1.1M | Seed | Jan 22, 2020 |  |

10 of 25 investments shown.

## Co-investors
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 2 deals together
- [BoxGroup](https://shizune.co/investors/profile/boxgroup) — VC Fund, 2 deals together
- [Index Ventures](https://shizune.co/investors/profile/index-ventures) — VC Fund, 2 deals together
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund, 2 deals together
- [9Yards Capital](https://shizune.co/investors/profile/9yards-capital) — VC Fund, 1 deal together
- [Acurio Ventures](https://shizune.co/investors/profile/acurio-ventures) — VC Fund, 1 deal together

## About Goggo Network

VC Fund · Berlin, Germany

Goggo is developing the legal and engineering framework of European autonomous mobility networks.Goggo strives to lead the driverless revolution in order to solve the transportation challenges of today heavy traffic, pollution etc. their vision is to provide all people with autonomous, electric and shared mobility solutions through the creation ofAutonomous Mobility Networks.

3 contacts available at Goggo Network.

| Name | Title | Profile |
| --- | --- | --- |
| Martin Varsavsky | Chairman & CEO | https://shizune.co/investors/profile/martin-varsavsky |
| Michael Fernandez-Ferri | VP of Product | https://shizune.co/investors/profile/michael-fernandez-ferri |
| Yasmine Fage | Chief Operating Officer & Co-Founder | https://shizune.co/investors/profile/yasmine-fage |

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Newtopia VC](https://shizune.co/investors/profile/newtopia-vc) — VC Fund
- [NXTP Ventures](https://shizune.co/investors/profile/nxtp-ventures) — VC Fund
- [Alaya Capital](https://shizune.co/investors/profile/alaya-capital) — VC Fund

## Featured in investor lists
- [Social Media Angel Investors](https://shizune.co/investors/social-media-angel-investors)
- [Social Media Angel Investors in Europe](https://shizune.co/investors/social-media-angel-investors-europe)
- [SaaS Angel Investors in Argentina](https://shizune.co/investors/saas-angel-investors-argentina)
- [Enterprise Angel Investors in Argentina](https://shizune.co/investors/enterprise-angel-investors-argentina)
- [All Angel Investors in Argentina](https://shizune.co/investors/angel-investors-argentina)
- [Enterprise Investors in Argentina](https://shizune.co/investors/enterprise-investors-argentina)

## FAQ

### What does Martin Varsavsky invest in?

Martin Varsavsky invests primarily in Software, Health Care and Social Media startups, most often at Seed and Series A stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Martin Varsavsky's check size?

Martin Varsavsky typically joins rounds of $424k–$3.3M at Seed, $212k–$1.1M at Angel and $4.3M–$77M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Martin Varsavsky participates in.

### When did Martin Varsavsky last invest?

The most recent investment recorded for Martin Varsavsky closed in Apr 2026. Shizune tracks 25 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co